Subcutaneous methylnaltrexone for the treatment of opioid-induced constipation in patients with chronic, nonmalignant pain: Safety results in patients treated for 12 weeks

Authors
Category Primary study
JournalJournal of Pain
Year 2010
This article has no abstract
Epistemonikos ID: 2198adc73ba5fa097a9994253b685668fae05b4c
First added on: Feb 28, 2025